LKYSF - Numinus Wellness Closes Q3 2021 With $63.2 Million Cash Position Lab and Trial Advances and Strategic Expansion into Psychedelic Neurology
VANCOUVER, BC, July 29, 2021 /CNW/ - Numinus Wellness Inc. (TSXV:NUMI)(OTCPK:LKYSF)("Numinus" or the "Company"), a mental health care company advancing innovative treatments and safe, evidence-based psychedelic-assisted therapies, today announced its fiscal third-quarter results ended May 31, 2021.
In the third quarter, Numinus maintained a healthy cash position, achieved key milestones in its lab and proprietary portfolio, expanded the clinic network, and continued to advance its basic and clinical research.
All financial results are reported in Canadian dollars unless otherwise stated.
Q3 2021 Highlights: Cash balance of $63.2 million as at May 31, 2021. ...Get early insight on hidden secret gems on StockStreetNews . Follow Crypto, Mining, Cannabis and Energy stocks and get free research reports here .
All content provided by StockStreetNews is subject to our Terms Of Use and Disclaimer .
For further details see:
Numinus Wellness Closes Q3 2021 With $63.2 Million Cash Position, Lab and Trial Advances, and Strategic Expansion into Psychedelic Neurology